Shares of Edgewell Personal Care surged 14.8% to $26.08 after Bloomberg reported that the maker of Schick razors and Hawaiian Tropic sunscreen rejected an unsolicited $30-per-share takeover bid from private equity firm Yellow Wood Partners. The board considered the offer too low , but the stock's violent jump — on a day when broader markets were weaker — tells a complicated story: investors didn't know this company was in play, and now they're scrambling to price in what comes next.
A PE Buyer With a Playbook for Exactly This Kind of Company. Yellow Wood is a Boston-based private equity firm with a portfolio that includes consumer brands such as Chapstick lip balm, Dr. Scholl's foot products, and Noxzema skin care. It also recently acquired Elida Beauty, a portfolio of legacy Unilever beauty and personal care brands, which it now operates as an independent company. Edgewell — with its stable but slow-growing stable of shaving, sun care, and grooming brands — fits that template perfectly, which is why the market is betting Yellow Wood won't walk away quietly.
The $30 Offer Already Looked Generous on Paper. Before Monday's close, Edgewell traded at just $22.72 — meaning the rejected bid carried a 32% premium. The company's shares have risen roughly 33% this year, bringing its market cap to about $1.05 billion; including debt, its enterprise value is approximately $2 billion. One Seeking Alpha analyst had recently rated the stock a Buy with a $30 target — the exact price Yellow Wood offered. The board is essentially arguing the stock is undervalued even at the analysts' own target.
The Business Is Mid-Transformation, Which Cuts Both Ways. Edgewell completed the sale of its feminine care business to Essity for $340 million in February 2026 , and intends to use proceeds primarily to strengthen its balance sheet and pay down debt. Last quarter, adjusted EBITDA was $73.8 million on $519.5 million in revenue, with full-year EBITDA guidance of $255 million at the midpoint. But adjusted gross margins contracted 310 basis points due to inflation and tariffs. The board's bet is that a leaner, post-divestiture Edgewell will earn its way to a higher price. If margins keep compressing instead, that $30 may look generous in hindsight.
What Happens Now Defines the Trade. With the stock stalled at $26, the market is pricing in roughly even odds that a sweetened offer materializes. Brandes Investment Partners holds 14.39% of Edgewell's shares — a concentrated institutional block that could pressure the board either way. Shareholders now face a binary bet: management delivers on its standalone turnaround, or Yellow Wood comes back with a higher number.